Onconic Therapeutics Inc. (KOSDAQ:476060)
21,150
+150 (0.71%)
Apr 10, 2026, 3:30 PM KST
315.72% (1Y)
| Market Cap | 942.64B +523.6% |
| Revenue (ttm) | 53.39B +259.8% |
| Net Income | 15.78B |
| EPS | n/a |
| Shares Out | 44.89M |
| PE Ratio | 59.72 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 235,030 |
| Average Volume | 634,128 |
| Open | 21,550 |
| Previous Close | 21,000 |
| Day's Range | 20,850 - 21,550 |
| 52-Week Range | 4,993 - 28,900 |
| Beta | n/a |
| RSI | 48.89 |
| Earnings Date | Mar 20, 2026 |